RPL7P51

Across TCGA pan-cancer cohorts, RPL7P51 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of RPL7P51’s most consistent transcriptional readouts.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where RPL7P51 RNA is repressed in tumor relative to normal tissue. In most cancer types RPL7P51 is over-expressed in tumor, although a few such as LUSC and PAAD show the opposite, repressed pattern.

LUSC, PAAD, and KICH are the cancer types where RPL7P51 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPL7P51 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUSC	All	II,III,IV	−0.067	.021	3	view →
PAAD	Male	All	−0.130	.005	2	view →
KICH	All	All	−0.059	.012	2	view →
KIRC	Female	All	−0.056	.016	2	view →
STAD	All	II,III,IV	+0.139	.034	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

RPL7P51–LUSC

Open the LUSC breakdown →